，/PRNewswire/ -- Robbins Geller Rudman &amp; Dowd LLP 律师事务所宣布，C3.ai 集体诉讼案 – 标题为 Liggett v. C3.ai, Inc.，案号 No. 25-cv-07129 (N.D. Cal.) – 旨在代表购买或获取 C3.ai, Inc. (NYSE: AI) 证券的投资者，并指控 C3.ai 及其部分高管违反了 1934 年证券交易法。
如果您遭受了重大损失并希望成为 C3.ai 集体诉讼的主诉人，请在此提供您的信息： https://www.rgrdlaw.com/cases-c3-ai-class-action-lawsuit-ai.html
您也可以通过拨打 800/449-4900 或发送电子邮件至 [email protected] 联系 Robbins Geller 的律师 J.C. Sanchez 或 Jennifer N. Caringal。C3.ai 集体诉讼的主诉人动议必须在 2025 年 10 月 21 日（星期二）之前提交法院。
案件指控：C3.ai 作为一家企业人工智能（&#34;AI&#34;）应用软件公司运营。
C3.ai 集体诉讼指控被告制造了虚假的印象，声称他们拥有关于 C3.ai 预期收入前景和预期增长的可靠信息，同时也最小化了因被告首席执行官 Thomas M. Siebel 的健康问题对 C3.ai 盈利能力的风险。根据投诉，C3.ai 对增长、盈利潜力和预期利润率的乐观报告与现实相去甚远，因为它们过于依赖于 C3.ai 首席执行官的健康和有效性。
C3.ai 集体诉讼进一步指控，2025 年 8 月 8 日，C3.ai 宣布了 2026 财年第一季度令人失望的初步财务结果，并下调了 2026 财年的收入指引，归因于 “与新领导层的重组” 和首席执行官的健康问题。根据投诉，C3.ai 股票价格因此下跌超过 25%。
主诉人程序：1995 年《私人证券诉讼改革法》允许在集体诉讼期间购买或获取 C3.ai 证券的任何投资者申请成为 C3.ai 集体诉讼的主诉人。主诉人通常是寻求的救济中具有最大财务利益的动议人，同时也是潜在集体的典型和适当代表。主诉人代表所有其他集体成员指导 C3.ai 集体诉讼。主诉人可以选择其所选择的律师事务所来进行 C3.ai 集体诉讼。投资者分享任何潜在未来赔偿的能力并不依赖于作为 C3.ai 集体诉讼的主诉人。
关于 ROBBINS GELLER：Robbins Geller Rudman &amp; Dowd LLP 是全球领先的代表投资者进行证券欺诈和股东诉讼的律师事务所之一。我们的事务所过去五年中有四年在 ISS 证券集体诉讼服务排名中被评为第一，因其为投资者争取到最多的金钱赔偿。根据 ISS，2024 年我们为证券相关集体诉讼案件为投资者追回了超过 25 亿美元，超过了下五家律师事务所的总和。Robbins Geller 在 10 个办公室拥有 200 名律师，是全球最大的原告律师事务所之一，事务所的律师获得了历史上许多最大的证券集体诉讼赔偿，包括历史上最大的赔偿——72 亿美元——在 In re Enron Corp. Sec. Litig. 案件中。有关更多信息，请访问以下页面：
https://www.rgrdlaw.com/services-litigation-securities-fraud.html
过去的结果并不保证未来的结果。
服务可能由我们任何办公室的律师提供。
联系方式：
Robbins Geller Rudman &amp; Dowd LLP
J.C. Sanchez, Jennifer N. Caringal
655 W. Broadway, Suite 1900, San Diego, CA 92101
800-449-4900 [email protected]
来源 Robbins Geller Rudman &amp; Dowd LLP
<img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwOTE5Jk5ld3NJdGVtSWQ9TEE3NzQyMSZUcmFuc21pc3Npb25fSWQ9MjAyNTA5MTkxNDA1UFJfTkVXU19VU1BSX19fX19MQTc3NDIx?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwOTE5Jk5ld3NJdGVtSWQ9TEE3NzQyMSZUcmFuc21pc3Npb25fSWQ9MjAyNTA5MTkxNDA1UFJfTkVXU19VU1BSX19fX19MQTc3NDIx"/>

C3.ai, Inc. 的投资者如果遭受重大损失，有机会对该公司及其高管提起集体诉讼，指控其违反 1934 年证券交易法。诉讼声称，C3.ai 错误地表述了其收入前景，并淡化了与首席执行官托马斯·M·西贝尔健康状况相关的风险。在 2025 年 8 月 8 日公布令人失望的财务结果后，C3.ai 的股价下跌超过 25%。有意担任首席原告的投资者必须在 2025 年 10 月 21 日前提交动议

, /PRNewswire/ -- The law firm of Robbins Geller Rudman &amp; Dowd LLP announces that the C3.ai class action lawsuit – captioned Liggett v. C3.ai, Inc., No. 25-cv-07129 (N.D. Cal.) – seeks to represent purchasers or acquirers of C3.ai, Inc. (NYSE: AI) securities and charges C3.ai as well as certain of C3.ai's top executives with violations of the Securities Exchange Act of 1934.
<div class="lb-trans">，/PRNewswire/ -- Robbins Geller Rudman &amp; Dowd LLP 律师事务所宣布，C3.ai 集体诉讼案 – 标题为 Liggett v. C3.ai, Inc.，案号 No. 25-cv-07129 (N.D. Cal.) – 旨在代表购买或获取 C3.ai, Inc. (NYSE: AI) 证券的投资者，并指控 C3.ai 及其部分高管违反了 1934 年证券交易法。
</div>If you suffered substantial losses and wish to serve as lead plaintiff of the C3.ai class action lawsuit, please provide your information here: https://www.rgrdlaw.com/cases-c3-ai-class-action-lawsuit-ai.html
<div class="lb-trans">如果您遭受了重大损失并希望成为 C3.ai 集体诉讼的主诉人，请在此提供您的信息： https://www.rgrdlaw.com/cases-c3-ai-class-action-lawsuit-ai.html
</div>You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected]. Lead plaintiff motions for the C3.ai class action lawsuit must be filed with the court no later than Tuesday, October 21, 2025.
<div class="lb-trans">您也可以通过拨打 800/449-4900 或发送电子邮件至 [email protected] 联系 Robbins Geller 的律师 J.C. Sanchez 或 Jennifer N. Caringal。C3.ai 集体诉讼的主诉人动议必须在 2025 年 10 月 21 日（星期二）之前提交法院。
</div>CASE ALLEGATIONS: C3.ai operates as an enterprise artificial intelligence (&#34;AI&#34;) application software company.
<div class="lb-trans">案件指控：C3.ai 作为一家企业人工智能（&#34;AI&#34;）应用软件公司运营。
</div>The C3.ai class action lawsuit alleges that defendants created the false impression that they possessed reliable information pertaining to C3.ai's projected revenue outlook and anticipated growth while also minimizing risk to C3.ai's profitability from defendant CEO Thomas M. Siebel's health concerns. In truth, according to the complaint, C3.ai's optimistic reports of growth, earnings potential, and anticipated margins fell short of reality as they relied far too heavily on the health and effectiveness of C3.ai's CEO.
<div class="lb-trans">C3.ai 集体诉讼指控被告制造了虚假的印象，声称他们拥有关于 C3.ai 预期收入前景和预期增长的可靠信息，同时也最小化了因被告首席执行官 Thomas M. Siebel 的健康问题对 C3.ai 盈利能力的风险。根据投诉，C3.ai 对增长、盈利潜力和预期利润率的乐观报告与现实相去甚远，因为它们过于依赖于 C3.ai 首席执行官的健康和有效性。
</div>The C3.ai class action lawsuit further alleges that on August 8, 2025, C3.ai announced disappointing preliminary financial results for the first quarter of fiscal year 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing its poor sales results and lowered guidance on &#34;the reorganization with new leadership&#34; and the health ailments of its CEO. On this news, the price of C3.ai stock fell more than 25%, according to the complaint.
<div class="lb-trans">C3.ai 集体诉讼进一步指控，2025 年 8 月 8 日，C3.ai 宣布了 2026 财年第一季度令人失望的初步财务结果，并下调了 2026 财年的收入指引，归因于 “与新领导层的重组” 和首席执行官的健康问题。根据投诉，C3.ai 股票价格因此下跌超过 25%。
</div>THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired C3.ai securities during the Class Period to seek appointment as lead plaintiff in the C3.ai class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the C3.ai class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the C3.ai class action lawsuit. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the C3.ai class action lawsuit.
<div class="lb-trans">主诉人程序：1995 年《私人证券诉讼改革法》允许在集体诉讼期间购买或获取 C3.ai 证券的任何投资者申请成为 C3.ai 集体诉讼的主诉人。主诉人通常是寻求的救济中具有最大财务利益的动议人，同时也是潜在集体的典型和适当代表。主诉人代表所有其他集体成员指导 C3.ai 集体诉讼。主诉人可以选择其所选择的律师事务所来进行 C3.ai 集体诉讼。投资者分享任何潜在未来赔偿的能力并不依赖于作为 C3.ai 集体诉讼的主诉人。
</div>ABOUT ROBBINS GELLER: Robbins Geller Rudman &amp; Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:
<div class="lb-trans">关于 ROBBINS GELLER：Robbins Geller Rudman &amp; Dowd LLP 是全球领先的代表投资者进行证券欺诈和股东诉讼的律师事务所之一。我们的事务所过去五年中有四年在 ISS 证券集体诉讼服务排名中被评为第一，因其为投资者争取到最多的金钱赔偿。根据 ISS，2024 年我们为证券相关集体诉讼案件为投资者追回了超过 25 亿美元，超过了下五家律师事务所的总和。Robbins Geller 在 10 个办公室拥有 200 名律师，是全球最大的原告律师事务所之一，事务所的律师获得了历史上许多最大的证券集体诉讼赔偿，包括历史上最大的赔偿——72 亿美元——在 In re Enron Corp. Sec. Litig. 案件中。有关更多信息，请访问以下页面：
</div>https://www.rgrdlaw.com/services-litigation-securities-fraud.html
<div class="lb-trans">https://www.rgrdlaw.com/services-litigation-securities-fraud.html
</div>Past results do not guarantee future outcomes.
<div class="lb-trans">过去的结果并不保证未来的结果。
</div>Services may be performed by attorneys in any of our offices.
<div class="lb-trans">服务可能由我们任何办公室的律师提供。
</div>Contact:
<div class="lb-trans">联系方式：
</div>Robbins Geller Rudman &amp; Dowd LLP
<div class="lb-trans">Robbins Geller Rudman &amp; Dowd LLP
</div>J.C. Sanchez, Jennifer N. Caringal
<div class="lb-trans">J.C. Sanchez, Jennifer N. Caringal
</div>655 W. Broadway, Suite 1900, San Diego, CA 92101
<div class="lb-trans">655 W. Broadway, Suite 1900, San Diego, CA 92101
</div>800-449-4900 [email protected]
<div class="lb-trans">800-449-4900 [email protected]
</div>SOURCE Robbins Geller Rudman &amp; Dowd LLP
<div class="lb-trans">来源 Robbins Geller Rudman &amp; Dowd LLP
</div><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwOTE5Jk5ld3NJdGVtSWQ9TEE3NzQyMSZUcmFuc21pc3Npb25fSWQ9MjAyNTA5MTkxNDA1UFJfTkVXU19VU1BSX19fX19MQTc3NDIx" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=LA77421&amp;Transmission_Id=202509191405PR_NEWS_USPR_____LA77421&amp;DateId=20250919"/>

14:05 ET
			
			
				C3.AI INVESTOR DEADLINE: C3.ai, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

- C3.ai 正面临集体诉讼，指控其及高管违反证券法。  
- 诉讼称 C3.ai 误导投资者，未披露 CEO 健康问题对盈利的影响。  
- 2025 年 8 月，C3.ai 发布财报不佳，股价下跌超过 25%。

C3.AI 投资者截止日期：C3.ai, Inc.的投资者如果遭受重大损失，有机会主导投资者集体诉讼